[Form 4] Lifeward Ltd. Insider Trading Activity

Rhea-AI Filing Summary

Adar Almog, identified on the form as the company’s Chief Financial Officer, received a grant of stock options under the 2025 Incentive Compensation Plan. The award covers 225,000 options with an exercise price of $0.717 per share and was recorded with a transaction date of 08/13/2025. The options vest in four equal annual installments beginning 08/13/2026 and expire on 08/13/2035, and are reported as a direct holding tied to 225,000 ordinary shares (par value NIS 1.75). The form states a price of the derivative security of $0 and notes vesting is subject to continued service.

Insights

Securities Analyst

TL;DR: CFO granted 225,000 options at $0.717, vesting over four years, direct holding; transaction appears compensatory, not a sale.

The filing documents a compensatory option grant to the Chief Financial Officer totaling 225,000 options under the company’s 2025 Incentive Compensation Plan. Key terms are explicit: a $0.717 exercise price, four-year vesting in equal annual installments beginning one year after grant, and an expiration roughly ten years from grant. The award is reported as a direct beneficial holding of derivative securities. The form does not report any cash exercise or disposition; it records an acquisition of derivative awards.

Corporate Governance Expert

TL;DR: Grant follows standard vesting structure; disclosure shows direct ownership of options and service-based vesting conditions.

The submission specifies the grant mechanism and vesting condition: options were issued under the 2025 Incentive Compensation Plan and vest subject to continued service in four equal annual tranches. The report lists the underlying security as ordinary shares (par value NIS 1.75) and provides an expiration date, fulfilling key disclosure elements for insider compensation. No amendments, sales, or derivative exercises are reported on this form.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Adar Almog

(Last) (First) (Middle)

C/O REWALK ROBOTICS LTD.

3 HATNUFA ST., P.O. BOX 161

(Street)

YOKNEAM ILIT L3 20692203

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Lifeward Ltd. [ LFWD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (Right to Buy)	$0.717	08/13/2025		A		225,000		(1)	08/13/2035	Ordinary Shares, par value NIS 1.75 per share	225,000	$0	225,000	D

Explanation of Responses:

1. Represents stock options granted under the 2025 Incentive Compensation Plan on August 13, 2025. The option shall vest and become exercisable in four equal annual installments beginning on August 13, 2026, subject to the Reporting Person's continued service as of each such vesting date.

	/s/ Almog Adar	08/13/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.